BioTime ' s Renevia Succeeds in Pivotal European Facial Wasting Trial BioTime ' s Renevia Succeeds in Pivotal European Facial Wasting Trial

BioTime Inc said on Wednesday its Renevia system succeeded in meeting the main goal of a pivotal European trial for facial wasting associated with treatment for HIV, putting it on track to file for European approval this year.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Nephrology News Source Type: news